Insmed | Ativo Circulante



Current Assets Alterar Data
BioMarin Pharmaceutical USD 3.81B 337.43M 2025-06
Cytokinetics USD 886.54M 69.51M 2025-06
DBV Technologies USD 121.24M 92.09M 2025-06
Dynavax Technologies USD 785.71M 30.26M 2025-06
Gilead Sciences USD 14.72B 2.18B 2025-06
Insmed USD 2.08B 678.89M 2025-06
Novartis USD 25.94B 3.76B 2025-06
Regeneron Pharmaceuticals USD 16.86B 712.2M 2025-06
Sarepta Therapeutics USD 2.66B 224.45M 2025-06
Ultragenyx Pharmaceutical USD 719.79M 20.63M 2025-06
Vertex Pharmaceuticals USD 10.43B 419.1M 2025-06


Insmed Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Sep 2025.